JPRN-UMIN000015825
Completed
未知
Can Immunohistochemical markers be a prognostic factors in malignant pleural mesothelioma patients? - Can Immunohistochemical markers be a prognostic factors in malignant pleural mesothelioma patients?
Hyogo Prefectural Amagasaki Hospital0 sites350 target enrollmentDecember 10, 2014
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Hyogo Prefectural Amagasaki Hospital
- Enrollment
- 350
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients with simultaneous multiple cancer Patients diagnosed with tissue type other than a biphasic or epitherial mesotherioma Patients who had been diagnosed with autopsy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Not Applicable
Role of Geminin and Mcm-2 in Prognosis of Renal Cell CarcinomaRenal Cell CarcinomaNCT03692533Assiut University80
Recruiting
Not Applicable
Determining prognostic immune markers in patients with ovarian cancer * a prospective explorative cohort study.NL-OMON48676eids Universitair Medisch Centrum300
Not yet recruiting
Not Applicable
Immunohematogical markers in Graves diseaseHealth Condition 1: E050- Thyrotoxicosis with diffuse goiterCTRI/2021/12/038899Jayanthy Ramesh
Not yet recruiting
Not Applicable
Investigation of biomarkers to predict immune-related adverse events in patients with non-small cell lung canceron-small cell lung cancerJPRN-UMIN000047162Kobe University114
Not yet recruiting
Not Applicable
se of immunohistochemistry and direct immunofluorescence in diagnosis of primary cicatricial alopeciaHealth Condition 1: L00-L99- Diseases of the skin and subcutaneous tissueCTRI/2020/07/026308Maulana Azad Medical College